Literature DB >> 2893297

Analysis of the receptors mediating vascular actions of bradykinin.

E T Whalley1, I A Nwator, J M Stewart, R J Vavrek.   

Abstract

A range of bradykinin (BK) analogues was assessed for their ability to antagonise the action of BK on rabbit jugular vein, a B2-receptor containing tissue, and compared with their action against BK-induced increases in skin vascular permeability in the rabbit and rat. The results demonstrate that modification of the BK (nonapeptide) structure by the insertion of certain D-amino acids in positions 5, 7 and 8 in addition to elongation of the amino terminal resulted in compounds with potent antagonistic action against BK on rabbit jugular vein and rabbit skin vascular permeability. The same BK analogues did not antagonise the action of BK on rat skin vascular permeability. It is concluded that the kinin receptor mediating an increase in vascular permeability in the rabbit is the same as that mediating contraction of the rabbit jugular vein in vitro, that is the B2-type. The kinin receptor mediating an increase in skin vascular permeability in the rat is difficult to classify but does not appear to be of the B2 type.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893297     DOI: 10.1007/bf00164878

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  Substances which affect capillary permeability.

Authors:  W G SPECTOR
Journal:  Pharmacol Rev       Date:  1958-12       Impact factor: 25.468

2.  pA, a new scale for the measurement of drug antagonism.

Authors:  H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1947-09

3.  Release of histamine from mast cells by vasoactive peptides.

Authors:  A R Johnson; E G Erdös
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

4.  Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights.

Authors:  M L Reis; L Okino; M Rocha e Silva
Journal:  Biochem Pharmacol       Date:  1971-11       Impact factor: 5.858

Review 5.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

6.  Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin.

Authors:  F Marceau; M Knap; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1981-09       Impact factor: 2.273

Review 7.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

8.  Potency of various peptides as histamine liberators in the rat hind limb.

Authors:  F Rioux; R Kérouac; S St-Pierre
Journal:  Neuropeptides       Date:  1985-07       Impact factor: 3.286

9.  Receptors mediating the increase in vascular permeability to kinins: comparative studies in rat, guinea-pig and rabbit.

Authors:  E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

10.  The actions of kinin antagonists on B1 and B2 receptor systems.

Authors:  D Regoli; G Drapeau; P Rovero; S Dion; P D'Orléans-Juste; J Barabé
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

View more
  11 in total

1.  A bradykinin antagonist inhibits carrageenan edema in rats.

Authors:  R M Burch; C DeHaas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Neurotransmitter release from bradykinin-stimulated PC12 cells. Stimulation of cytosolic calcium and neurotransmitter release.

Authors:  K C Appell; D S Barefoot
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

Review 3.  Hereditary angioedema in childhood: an approach to management.

Authors:  Didier G Ebo; Marjoke M Verweij; Kathleen J De Knop; Margo M Hagendorens; Chris H Bridts; Luc S De Clerck; Wim J Stevens
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

4.  Multiple mechanisms in the motor responses of the guinea-pig isolated urinary bladder to bradykinin.

Authors:  C A Maggi; R Patacchini; P Santicioli; P Geppetti; R Cecconi; S Giuliani; A Meli
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor.

Authors:  Eun D Han; Ryan C MacFarlane; Aideen N Mulligan; Jennifer Scafidi; Alvin E Davis
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Effects of fepradinol on rat acute models of vascular permeability and leucocyte migration.

Authors:  J M Masso; A M Villar; J R Conde; J Martorell
Journal:  Agents Actions       Date:  1994-10

7.  The neuropeptide bradykinin stimulates phosphoinositide turnover in HSDM1C1 cells: B2-antagonist-sensitive responses and receptor binding studies.

Authors:  N A Sharif; R L Whiting
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

8.  The effect of kinin agonists and antagonists on the pain response of the human blister base.

Authors:  E T Whalley; S Clegg; J M Stewart; R J Vavrek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Plasma exudation in conscious dogs with experimental heart failure.

Authors:  I Rubinstein; G Müns; I H Zucker
Journal:  Basic Res Cardiol       Date:  1994 Sep-Oct       Impact factor: 17.165

10.  Attenuation of arterial blood pressure fall in endotoxin shock in the rat using the competitive bradykinin antagonist Lys-Lys-[Hyp2, Thi5,8, DPhe7]-Bk (B4148).

Authors:  J Weipert; H Hoffmann; M Siebeck; E T Whalley
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.